Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1980 Apr 5;280(6219):964–966. doi: 10.1136/bmj.280.6219.964-a

Do drugs change the course of rheumatoid arthritis?

V Wright, R Amos
PMCID: PMC1601115  PMID: 6106520

Full text

PDF
966

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos R. S., Constable T. J., Crockson R. A., Crockson A. P., McConkey B. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J. 1977 Jan 22;1(6055):195–197. doi: 10.1136/bmj.1.6055.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CHANDLER G. N., WRIGHT V. Deleterious effect of intra-articular hydrocortisone. Lancet. 1958 Sep 27;2(7048):661–663. doi: 10.1016/s0140-6736(58)92262-1. [DOI] [PubMed] [Google Scholar]
  3. Currey H. L., Harris J., Mason R. M., Woodland J., Beveridge T., Roberts C. J., Vere D. W., Dixon A. S., Davies J., Owen-Smith B. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. Br Med J. 1974 Sep 28;3(5934):763–766. doi: 10.1136/bmj.3.5934.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Day A. T., Golding J. R., Lee P. N., Butterworth A. D. Penicillamine in rheumatoid disease: a long-term study. Br Med J. 1974 Feb 2;1(5900):180–183. doi: 10.1136/bmj.1.5900.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dixon A. J., Davies J., Dormandy T. L., Hamilton E. B., Holt P. J., Mason R. M., Thompson M., Weber J. C., Zutshi D. W. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis. 1975 Oct;34(5):416–421. doi: 10.1136/ard.34.5.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gerber D. A., Gerber M. G. Specificity of a low free serum histidine concentration for rheumatoid arthritis. J Chronic Dis. 1977 Feb;30(2):115–127. doi: 10.1016/0021-9681(77)90079-0. [DOI] [PubMed] [Google Scholar]
  7. Gerber D. A. Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity. J Clin Invest. 1975 Jun;55(6):1164–1173. doi: 10.1172/JCI108033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HAMILTON E. B., SCOTT J. T. Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis. Arthritis Rheum. 1962 Oct;5:502–512. doi: 10.1002/art.1780050507. [DOI] [PubMed] [Google Scholar]
  9. Jaffe I. A. The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthritis Rheum. 1970 Jul-Aug;13(4):436–443. doi: 10.1002/art.1780130412. [DOI] [PubMed] [Google Scholar]
  10. Mason M., Currey H. L., Barnes C. G., Dunne J. F., Hazleman B. L., Strickland I. D. Azathioprine in rheumatoid arthritis. Br Med J. 1969 Feb 15;1(5641):420–422. doi: 10.1136/bmj.1.5641.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McConkey B., Amos R. S., Butler E. P., Crockson R. A., Crockson A. P., Walsh L. Salazopyrin in rheumatoid arthritis. Agents Actions. 1978 Jun;8(4):438–441. doi: 10.1007/BF01968673. [DOI] [PubMed] [Google Scholar]
  12. McConkey B., Crockson R. A., Crockson A. P. The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants. Q J Med. 1972 Apr;41(162):115–125. [PubMed] [Google Scholar]
  13. McConkey B., Crockson R. A., Crockson A. P., Wilkinson A. R. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. Q J Med. 1973 Oct;42(168):785–791. [PubMed] [Google Scholar]
  14. McConkey B., Davies P., Crockson R. A., Crockson A. P., Butler M., Constable T. J., Amos R. S. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis. 1979 Apr;38(2):141–144. doi: 10.1136/ard.38.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Morley J. Prostaglandins and lymphokines in inflammation. Rheumatol Rehabil. 1978;Suppl:18–24. doi: 10.1093/rheumatology/xvii.suppl.18. [DOI] [PubMed] [Google Scholar]
  16. POPERT A. J., MEIJERS K. A., SHARP J., BIER F. Chloroquine diphosphate in rheumatoid arthritis. A controlled trial. Ann Rheum Dis. 1961 Mar;20:18–35. doi: 10.1136/ard.20.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Runge L. A., Pinals R. S., Lourie S. H., Tomar R. H. Treatment of rheumatoid arthritis with levamisole. A controlled trial. Arthritis Rheum. 1977 Nov-Dec;20(8):1445–1448. doi: 10.1002/art.1780200801. [DOI] [PubMed] [Google Scholar]
  19. Sigler J. W., Bluhm G. B., Duncan H., Sharp J. T., Ensign D. C., McCrum W. R. Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med. 1974 Jan;80(1):21–26. doi: 10.7326/0003-4819-80-1-21. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES